Adam holds a First-Class Honours Degree in Biomedical Science from the University of Surrey, and an MSc in Science Communication from the University of Manchester.

Adam has 7+ years experience working in the market access strategy and value communication field, working with pharmaceutical and medical device companies throughout their products lifecycle, to optimise their commercial potential, value and market access strategy.

Adam has experience in leading and delivering an extensive range projects, from early disease landscaping, pricing opportunity assessments and launch strategy development, through to evidence generation, value tools, HTA submissions, and stakeholder insights. His experience spans across numerous global markets as well as disease areas, including rare diseases, cardiology, neurology, respiratory, diabetes etc.

‍

"Being part of a journey that helps to bring new and innovative medicines to patients, particularly those with a high unmet need, is what drives me in my career"